rs768983518

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001286272.2(TPT1):​c.571T>C​(p.Leu191Leu) variant causes a synonymous change. The variant allele was found at a frequency of 0.0000506 in 1,461,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000051 ( 0 hom. )

Consequence

TPT1
NM_001286272.2 synonymous

Scores

2

Clinical Significance

risk factor no assertion criteria provided O:1

Conservation

PhyloP100: 4.50

Publications

2 publications found
Variant links:
Genes affected
TPT1 (HGNC:12022): (tumor protein, translationally-controlled 1) This gene encodes a protein that is a regulator of cellular growth and proliferation. Its mRNA is highly structured and contains an oligopyrimidine tract (5'-TOP) in its 5' untranslated region that functions to repress its translation under quiescent conditions. The encoded protein is involved in a variety of cellular pathways, including apoptosis, protein synthesis and cell division. It binds to and stabilizes microtubules, and removal of this protein through phosphorylation is required for progression through mitotic and meiotic cell divisions. This gene is known to play a role in carcinogenesis, and is upregulated in some cancer cells. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2017]
SNORA31 (HGNC:32621): (small nucleolar RNA, H/ACA box 31)
SNORA31 Gene-Disease associations (from GenCC):
  • encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 10
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.086).
BS2
High AC in GnomAdExome4 at 74 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001286272.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TPT1
NM_003295.4
MANE Select
c.517-111T>C
intron
N/ANP_003286.1P13693-1
TPT1
NM_001286272.2
c.571T>Cp.Leu191Leu
synonymous
Exon 6 of 6NP_001273201.1A0A0B4J2C3
TPT1
NM_001286273.2
c.415-111T>C
intron
N/ANP_001273202.1P13693-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TPT1
ENST00000530705.6
TSL:1 MANE Select
c.517-111T>C
intron
N/AENSP00000431872.2P13693-1
TPT1
ENST00000379056.5
TSL:1
c.415-111T>C
intron
N/AENSP00000368345.1P13693-2
TPT1
ENST00000616577.4
TSL:3
c.571T>Cp.Leu191Leu
synonymous
Exon 6 of 6ENSP00000477781.1A0A0B4J2C3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000521
AC:
13
AN:
249708
AF XY:
0.0000369
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000442
Gnomad OTH exome
AF:
0.000329
GnomAD4 exome
AF:
0.0000506
AC:
74
AN:
1461720
Hom.:
0
Cov.:
31
AF XY:
0.0000399
AC XY:
29
AN XY:
727168
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.000157
AC:
7
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53260
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000576
AC:
64
AN:
1112006
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.000130
Hom.:
0
Bravo
AF:
0.0000302

ClinVar

ClinVar submissions
Significance:risk factor
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
-
Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 10 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Benign
20
DANN
Benign
0.90
PhyloP100
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs768983518; hg19: chr13-45911634; API